Law360, New York (January 20, 2011, 2:46 PM ET) -- Pharmaceutical company Pfizer Inc. has been accused of unlawfully terminating a patent licensing agreement for imaging technology between AntiCancer Inc. and Wyeth following the merger of the two drug giants.
San Diego-based AntiCancer filed its complaint for breach of license agreement, breach of implied covenant of good faith and fair dealing and unjust enrichment against Pfizer and 10 unknown parties Wednesday in the U.S. District Court for the Southern District of California.
AntiCancer agreed to grant Wyeth a limited, nonexclusive license to its patented technologies as...
Pfizer Sued Over Termination Of Wyeth Patent Pact
To view the full article, take a free trial now.
